loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Mycophenolate Mofetil Hydrochloride

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Mycophenolate Mofetil Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,699Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BPI's Generic Mycophenolate Mofetil Hydrochloride Receives Approval in the U.S.
    BPI's Generic Mycophenolate Mofetil Hydrochloride Receives Approval in the U.S.

    01 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214283

    FDA
    01 Jun 2023
    Share Share
    Steriscience's Generic Mycophenolate Mofetil Hydrochloride Receives Approval in the U.S.
    Steriscience's Generic Mycophenolate Mofetil Hydrochloride Receives Approval in the U.S.

    23 Dec 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216390

    FDA
    23 Dec 2022
    Share Share
    Novartis to pay $390 million in U.S. settlement over pharmacy kickbacks
    Novartis to pay $390 million in U.S. settlement over pharmacy kickbacks

    21 Nov 2015

    // Sarah N. Lynch REUTERS

    http://www.reuters.com/article/2015/11/20/us-novartis-pharmacies-kickbacks-idUSKCN0T92MR20151120?rpc=401#cf1zEqDuzgY1HpGE.97

    Sarah N. Lynch REUTERS
    21 Nov 2015
    Share Share
    CellCept,MYFORTIC-Risk of Teratogenicity in Mycophenolate-Containing Products
    CellCept,MYFORTIC-Risk of Teratogenicity in Mycophenolate-Containing Products

    12 Jan 2015

    // HEALTH CANADA

    http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/56690a-eng.php

    HEALTH CANADA
    12 Jan 2015
    Share Share